American Century Companies Inc. Purchases 19,383 Shares of Ingevity Corporation $NGVT

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. lifted its position in Ingevity Corporation (NYSE:NGVT - Free Report) by 1.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,476,748 shares of the company's stock after acquiring an additional 19,383 shares during the period. American Century Companies Inc. owned 4.05% of Ingevity worth $58,464,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP increased its position in Ingevity by 5.4% during the 4th quarter. Wellington Management Group LLP now owns 2,239,970 shares of the company's stock valued at $91,279,000 after buying an additional 115,581 shares in the last quarter. Royce & Associates LP increased its position in Ingevity by 5.8% during the 1st quarter. Royce & Associates LP now owns 1,208,445 shares of the company's stock valued at $47,842,000 after buying an additional 65,847 shares in the last quarter. Millennium Management LLC increased its position in Ingevity by 5.0% during the 4th quarter. Millennium Management LLC now owns 1,135,231 shares of the company's stock valued at $46,261,000 after buying an additional 53,807 shares in the last quarter. Brown Advisory Inc. increased its position in Ingevity by 1.1% during the 1st quarter. Brown Advisory Inc. now owns 938,820 shares of the company's stock valued at $37,168,000 after buying an additional 10,600 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Ingevity by 8.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 701,755 shares of the company's stock valued at $27,782,000 after buying an additional 55,488 shares in the last quarter. Institutional investors own 91.59% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. BMO Capital Markets raised their price objective on Ingevity from $56.00 to $62.00 and gave the company an "outperform" rating in a research report on Thursday, August 7th. Wall Street Zen raised Ingevity from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Wells Fargo & Company raised their price objective on Ingevity from $38.00 to $48.00 and gave the company an "equal weight" rating in a research report on Monday, July 14th.

Ingevity Stock Up 1.2%

Ingevity stock opened at $55.24 on Tuesday. The firm has a market cap of $2.01 billion, a price-to-earnings ratio of -9.28 and a beta of 1.36. The stock has a fifty day simple moving average of $46.02 and a two-hundred day simple moving average of $42.41. Ingevity Corporation has a 12 month low of $28.49 and a 12 month high of $55.89. The company has a current ratio of 1.36, a quick ratio of 0.80 and a debt-to-equity ratio of 10.24.

Ingevity (NYSE:NGVT - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.39 EPS for the quarter, topping analysts' consensus estimates of $1.02 by $0.37. The business had revenue of $365.10 million during the quarter, compared to analyst estimates of $378.70 million. Ingevity had a positive return on equity of 84.92% and a negative net margin of 16.35%. The company's quarterly revenue was down 6.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.01 EPS. Equities analysts predict that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.